Last update: 21/10/25
Connect with us:

Co-organized with the

Welcome

Scientific Program

Young Investigator Symposium, Poster Awards and Travel Support

Registration & Abstract Submission

All the sponsors

Venue Photos-Map

Travel Informationn

Hotel Reservation

Committees and Contact

Past-Workshops on Lipid Mediators

 

 


Program

PROGRAM
16 Invited speakers + 31 Talks selected from the submitted abstracts

Wednesday, July 1st (Duclaux amphitheater)
8:15 Registration with refreshments

Educational SESSION

9:00 – Opening address by chairpersons: xyx and xyx

9:05 - 9:30 – To be announced (TBA)* (25 min)

9:30 - 9:55 - TBA* (25 min)

9:55 - 10:20 - TBA* (25 min)

COFFEE BREAK (Modules, and Sponsor stands visit) 10:20 - 10h45

 

 1st Sponsored SESSION

(sponsored by TBA)
Lipid mediator analytics and biomarkers

10:45 - Welcome by chairpersons: Gijs Kooij and xyx

10:50 – 11:15 - Laura Bindila*
Medical University Mainz, Germany (25 min)
4D Lipidomics for cellular and circulatory phenotyping with diseases

11:15 – 11:40 - Ingela Lanekoff*
Uppsala University, Sweden (25 min)
Preliminary title: Mapping the distribution of lipid mediators in tissue

11:40 – 12:40 - Selected speakers tbd (e.g. 3x 20 min incl Q&A)

LUNCH BREAK 12:40 - 14:25 (Modules, and Sponsor stands visit)

 

2nd Sponsored SESSION

(sponsored by The Lipidomics Research and Study Group (GERLI)) 

Analytical challenges and clinical applications of oxylipins

14:25 - Welcome by chairpersons: Cécile Gladine and Thierry Durand

14.30 – 14.55 - Denise Biagini*
University of Pisa, Italy (25 min)
Unlocking oxylipin and PUFA profiling in unconventional biofluids:
Challenges, pitfalls, and clinical potential

14.55 – 15.20 - Craig Wheelock*
Karolinska Institutet, Stockholm, Sweden (25 min)
Title TBA

15:20 – 16:20 - Selected speakers tbd (e.g. 3 x 20 min incl Q&A)

 18:00 OPENING RECEPTION (CIS Building)

----------------------------------------------------------------------------------

Thursday, July 2nd (CIS Building)
8:15 Registration with refreshments
9:00 – Welcome address by xyx

9:05-9:45 Opening Plenary Lecture

Nan Chiang*
Brigham and Women's Hospital and Harvard Medical School, Boston, USA
Specialized pro-resolving mediators, their receptors and pathways:
Players in orchestrating resolution and regeneration

COFFEE BREAK (+ poster viewing, and Sponsor stands visit, CIS) 9:45 - 10:45

 

SESSION 1. 10:45 -12:20
Lipid mediators in Infection, inflammation and immunity

10:45 - Welcome by chairpersons: xyx and xyx

10:50 - 11:15 Julia Esser-von Bieren*
Technical University of Munich and Helmholtz Zentrum München, Germany
Role of macrophage-derived prostanoids in helminth infection

11:15 – 11:40 Jesmond Dalli*
William Harvey Research Institute - Queen Mary University of London, UK
Decoding resolution biology:
New insights into molecular dysregulation driving disease progression

11:40 – 11.53 - Selected speaker (13 min incl Q&A)

11:53 – 12.06 - Selected speaker (13 min incl Q&A)

12:06 – 12.20 - Selected speaker (13 min incl Q&A)

LUNCH BREAK 12:20 - 14:10 (Modules)


SESSION 2. 14:10 -15:45
Lipid mediator chemistry and molecular biology

14:10 - Welcome by chairpersons: xyx and xyx

14:15 - 14:40 - Derek J. Taylor*
Case Western Reserve University, Cleveland, USA
Structures of inhibitor-bound 15-PGDH:
insights into molecular mechanisms and regenerative therapeutic opportunities

14:40 - 15:05 - Martin Giera*
Leiden University Medical Center, Leiden, Netherlands
Lipid Mediator, Not Lipid Mediator:
Redefining Bioactive Lipids Beyond Oxylipins

15:05 – 15.18 - Selected speaker (13 min incl Q&A)

15:18 – 15.31 - Selected speaker (13 min incl Q&A)

15:31 – 15.45 - Selected speaker (13 min incl Q&A)

COFFEE BREAK (+ poster viewing, and Sponsor stands visit, CIS Building) 15:45 - 16:45



SESSION 3. 16:45 - 18:20
Lipid mediators in cancer biology

16:45 - Welcome by chairpersons: xyx and xyx

16:50 - 17:15 - Paola Patrignani*
G. d'Annunzio" University Medical School, Chieti, Italy
The crucial role of platelet eicosanoids in cancer:
An opportunity to prevent cancer development and metastasis
through targeted therapeutic interventions

17:15 – 17.40 - Anna Martling*
Karolinska Institutet & University Hospital, Stockholm, Sweden
Low-Dose Aspirin for Secondary Prevention in Colorectal Cancer:
Results from the Nordic ALASCCA Trial

- A 50% Reduction in Recurrence in Genetically Selected Patients

17:40 – 17.53 - Selected speaker (13 min incl Q&A)

17:53 – 18.06 - Selected speaker (13 min incl Q&A)

18:06 – 18.20 - Selected speaker (13 min incl Q&A)

19:30 GALA DINNER

--------------------------------------------------------------------------------

Friday, July 3rd (CIS Building)
8:15 Registration with refreshments
09:00 - 09:05 – Morning address by xyx

09:05 - 09:45 Plenary lecture

Vincenzo Di Marzo*
ICB-CNR, Pozzuoli, Italy / Université Laval, Québec City, Canada
The endocannabinoidome, the gut microbiome and dietary fatty acids:
a well functioning triangle.

COFFEE BREAK (+ poster viewing, and Sponsor stands visit, CIS Building) 9:45 - 10:25

 

SESSION 4. 10:25 - 12:00
Dietary lipids and supplements

10:25 - Welcome by chairpersons: xyx and xyx

10:30 - 10:55 - Robert Caesar*
University of Gothenburg, Sweden
Interaction between lipids and gut microbiota influences metabolic health

10:55 - 11:20 - Regina Rodrigo*
Principe Felipe Research Center (CIPF), Valencia, Spain
Inflammation resolution in retinal degeneration:
The emerging role of specialized pro-resolving lipid mediators in hereditary retinal diseases

11:20 – 11.33 - Selected speaker (13 min incl Q&A)

11:33 – 11.46- Selected speaker (13 min incl Q&A)

11:46 – 12.00 - Selected speaker (13 min incl Q&A) 

LUNCH BREAK 12:00 - 13:30 (Modules) 

 

YOUNG INVESTIGATOR SESSION 13:30 - 15:00
Talks (10 speakers) selected from the submitted abstracts
(7 + 2 min Q&A each, timed)

COFFEE BREAK (+ poster viewing, and Sponsor stands visit, CIS Building) 15:00 - 15:40

 

SESSION 5. 15.40 – 17.35
Lipid mediators in cardiovascular and metabolic diseases

15:40 - Welcome by chairpersons: xyx and xyx

15:45 - 16:10 - Philippe Gabriel Steg*
Bichat Hospital, INSERM U1148, Paris, France
Clinical trials of omega 3 fatty acids for cardiovascular prevention

16:10 - 16:35 - Magnus Bäck*
Karolinska Institutet & University Hospital, Stockholm; Sweden; INSERM U1116, Nancy, France
Resolving cardiovascular inflammation through omega-3-derived lipid mediators

16:35 – 16.48 - Selected speaker (13 min incl Q&A)

16:48 – 17.01- Selected speaker (13 min incl Q&A)

17:01 – 17.15 - Selected speaker (13 min incl Q&A)

 17.15 - Prize Winners and travel support announcements (Young session awards, Poster Prizes,etc)

17.35 - Adjourn: Workshop closing address by Xavier Norel & host for 11th EWLM

* indicates invited speaker

 

 



Sponsored session by

Our Sponsors:

 

Our Sponsors: